Under what circumstances you would consider treating stage II colon cancer with adjuvant chemotherapy?   

When would you consider use of ctDNA to help with this decision?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital
In an MMR deficient patient with high-risk feature...
Medical Oncologist at Mayo Clinic
This population was not well studied and I will be...
Medical Oncologist at Clinical Instructor
We have two other Q&A threads that discuss MMR...
Sign in or Register to read more